SOX-5 Transcription Factor: a Novel Psoriatic Autoantigen Preferentially Found in Women.

ACR Open Rheumatol · 2024 · PMC11638130 · PMID 39218617

Europe PMC DOI

hedged sentence

0.0840

closest p · 1.7× alpha

0.0840

boldest claim

The sentences

did not reach statistical significanceP = 0.084so close (0.05 < p ≤ 0.1)

We tested for a difference in anti‐SOX5 status by disease duration in the longitudinal analysis sample, and this did not reach statistical significance (anti‐SOX5–positive disease duration 27.2 ± 16.7 years and anti‐SOX5–negative 16.8 ± 12.3 years; P = 0.084).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.